EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   11:52:17 AM EDT
20.48
-0.33 (-1.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.02B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.78 Million
Adjusted EPS-$0.39
See more estimates
10-Day MA$21.77
50-Day MA$25.49
200-Day MA$14.99
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 121

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.